BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16389155)

  • 21. [Adjuvant therapy in rectal cancer].
    Lovas P; Lovasová Z
    Klin Onkol; 2011; 24(2):94-100. PubMed ID: 21644363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.
    Mendenhall WM; Vauthey JN; Zlotecki RA; Marsh RD; Copeland EM
    Semin Surg Oncol; 2003; 21(4):261-4. PubMed ID: 14648784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary treatment of resectable rectal cancer.
    Ayala DN; Russo SM; Blackstock AW
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):383-94. PubMed ID: 19673625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of radiation therapy in rectal cancer.
    Minsky BD
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-25-S18-29. PubMed ID: 9420018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neoadjuvant treatment of rectal cancer: towards an individualised therapy].
    Willeke F; Horisberger K; Post S
    Z Gastroenterol; 2006 Oct; 44(10):1053-63. PubMed ID: 17063435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Locally advanced rectal cancer: what is the evidence for induction chemoradiation?
    Glynne-Jones R; Harrison M
    Oncologist; 2007 Nov; 12(11):1309-18. PubMed ID: 18055850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Operative safety and oncologic outcomes of anal sphincter-preserving surgery with mesorectal excision for rectal cancer: 931 consecutive patients treated at a single institution.
    Kim NK; Kim YW; Min BS; Lee KY; Sohn SK; Cho CH
    Ann Surg Oncol; 2009 Apr; 16(4):900-9. PubMed ID: 19198951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language.
    Glynne-Jones R; Mawdsley S; Novell JR
    Colorectal Dis; 2006 Nov; 8(9):800-7. PubMed ID: 17032329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant therapy of rectal cancer.
    Minsky BD
    Semin Oncol; 1999 Oct; 26(5):540-4. PubMed ID: 10528902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between clinical trial participants and patients in a population-based registry: the German Rectal Cancer Study vs. the Rostock Cancer Registry.
    Kalata P; Martus P; Zettl H; Rödel C; Hohenberger W; Raab R; Becker H; Liersch T; Wittekind C; Sauer R; Fietkau R;
    Dis Colon Rectum; 2009 Mar; 52(3):425-37. PubMed ID: 19333042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total mesorectal excision and management of rectal cancer.
    Pinsk I; Phang PT
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1395-403. PubMed ID: 17944565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of neoadjuvant radiochemotherapy in treatment of locally advanced low rectal cancer].
    Yu BM; Zhang M; Wu WQ; Chen LW; Fu J; Fei CS; Shen Y
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):445-8. PubMed ID: 17686297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of circumferential resection margin following total mesorectal excision and adjuvant chemoradiotherapy in patients with rectal cancer.
    Baik SH; Kim NK; Lee YC; Kim H; Lee KY; Sohn SK; Cho CH
    Ann Surg Oncol; 2007 Feb; 14(2):462-9. PubMed ID: 17096053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
    Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
    Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
    Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal cancer.
    Legoux JL; Lehur PA; Penna C; Calais G; Roseau G; Calan LD
    Gastroenterol Clin Biol; 2006 Sep; 30 Spec No 2():2S43-2S51. PubMed ID: 17151562
    [No Abstract]   [Full Text] [Related]  

  • 39. Should preoperative or postoperative therapy be administered in the management of rectal cancer?
    Kachnic LA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S64-9. PubMed ID: 17178291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant therapy in rectal cancer.
    Cohen AM
    Hepatogastroenterology; 1992 Jun; 39(3):215-21. PubMed ID: 1505892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.